Figure 2.
Status of JAK 1/2 inhibitor clinical trials. The status of clinical development of various JAK 1/2 inhibitors. Drugs that are no longer in development are indicated by a cross.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.